Protara Therapeutics, Inc. (TARA) › Operating IncomeProtara Therapeutics, Inc. (TARA) — Operating IncomeAnnual figures by period end, from SEC filings.2012-12-31: -$8.00M2013-12-31: -$7.12M2014-12-31: -$7.58M2015-12-31: -$20.87M2016-12-31: -$28.70M2017-12-31: -$30.36M2018-12-31: -$21.37M2019-12-31: -$7.83M2020-12-31: -$34.44M2021-12-31: -$47.49M2022-12-31: -$67.06M2023-12-31: -$43.61M2024-12-31: -$49.15M2025-12-31: -$64.55M-$64.55M2012-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$64.55M—2026-03-10From 2025-01-012024-12-31-$49.15M—2026-03-10From 2024-01-012023-12-31-$43.61M—2025-03-05From 2023-01-012022-12-31-$67.06M—2024-03-13From 2022-01-012021-12-31-$47.49M—2023-03-08From 2021-01-012020-12-31-$34.44M—2022-03-09From 2020-01-012019-12-31-$7.83M—2021-03-11From 2019-01-012018-12-31-$21.37M—2020-03-20From 2018-01-012017-12-31-$30.36M—2019-03-13From 2017-01-012016-12-31-$28.70M—2019-03-13From 2016-01-012015-12-31-$20.87M—2018-03-14From 2015-01-012014-12-31-$7.58M—2017-03-16From 2014-01-012013-12-31-$7.12M—2016-03-14From 2013-01-012012-12-31-$8.00M—2015-03-20From 2012-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)